Evidence map›Paper›PMID 26525091›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2016

Aging-Related Considerations When Evaluating the Forced Expiratory Volume in 1 Second (FEV1) Over Time.

Carlos A Vaz Fragoso, Gail McAvay, Peter H Van Ness, E Jeffrey Metter, Luigi Ferrucci, H Klar Yaggi, John Concato, Thomas M Gill

Abstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Functional, molecular, and digital measurements of biological age.The Journal of clinical investigation · 2026
    Review
  2. Occupation and 11-year lung function decline in the HUNT Study.Occupational medicine (Oxford, England) · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. FEVRespiratory care · 2020
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Carlos A Vaz FragosoVeterans Affairs Clinical Epidemiology Research Center, West Haven, Connecticut. Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut. carlos.fragoso@yale.edu.
Gail McAvayDepartment of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Peter H Van NessDepartment of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
E Jeffrey MetterDepartment of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee.
Luigi FerrucciHarbor Hospital, National Institute on Aging, Baltimore, Maryland.
H Klar YaggiVeterans Affairs Clinical Epidemiology Research Center, West Haven, Connecticut. Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
John ConcatoVeterans Affairs Clinical Epidemiology Research Center, West Haven, Connecticut. Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Thomas M GillDepartment of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Denise Esserman · 2002 to 2026
$37.9M
MtDNA variant modifiers of cardiopulmonary responsiveness to physical activityR01HL121023 · NHLBI · UNIVERSITY OF FLORIDA · PI FRAGOSO, CARLOS A. VAZ, MANINI, TODD · 2014 to 2017
$1.3M
ACADEMIC LEADERSHIP AWARD IN DISABILITY AND DISABLING DISORDERSK07AG043587 · NIA · YALE UNIVERSITY · PI GILL, THOMAS MICHAEL · 2013 to 2017
$645k
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS R01 HL121023NIA NIH HHS K07 AG043587NIA NIH HHS P30 AG021342
6 · The paper itself

Abstract

backgroundForced expiratory volume in 1 second (FEV1) over time is commonly expressed in liters and percent predicted (%Pred), or alternatively in L/m(3) and Z-scores-which approach is more clinically meaningful has not been evaluated. Because it uniquely accounts for the effect of aging on FEV1 and spirometric performance, we hypothesized that the Z-score approach is more clinically meaningful, based on associations between cardiopulmonary predictors and FEV1 over time.

methodsUsing linear mixed-effects models and data from the Baltimore Longitudinal Study on Aging, including 501 white participants aged 40-95 who had completed at least three longitudinal spirometric assessments, we evaluated the associations between cardiopulmonary predictors (obesity, smoking status, hypertension, chronic bronchitis, diabetes mellitus, and myocardial infarction) and FEV1 over time, in liters, %Pred, L/m(3), and Z-scores.

resultsMean baseline values for FEV1 were 3.240L, 96.4%Pred, 0.621L/m(3), and -0.239 as a Z-score (40.6th percentile). The annual decline in FEV1 was 0.040L, 0.234 %Pred, 0.007L/m(3), and 0.008 Z-score units. Baseline age was associated with FEV1 over time in liters and L/m(3) (p < .001), and included a time interaction for %Pred (p < .001), but was not associated with Z-scores (p = .933). The associations of cardiopulmonary predictors with FEV1 over time were all significant when using Z-scores (p < .05), but varied for other methods of expressing FEV1.

conclusionA Z-score approach is more clinically meaningful when evaluating FEV1 over time, as it accounted for the effect of aging and was more frequently associated with multiple cardiopulmonary predictors.

Indexed as

Respiratory InsufficiencyAgedAgingBronchitis, ChronicDisease ProgressionFemaleForced Expiratory VolumeHealth Status DisparitiesHumansLongitudinal StudiesMaleMiddle AgedMyocardial InfarctionObesityPredictive Value of TestsResearch DesignAgingCardiovascular diseasesEpidemiologyLung diseasesSpirometry

Identifiers

PMID26525091
PMCPMC4906321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.